Latest Breaking News On - Prime medicine - Page 4 : comparemela.com

Prime Medicine, Inc (NYSE:PRME) Receives Average Rating of Moderate Buy from Analysts

Prime Medicine, Inc (NYSE:PRME) Receives Average Rating of Moderate Buy from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Stifel nicolausRobert nelsenSg americas securitiesOppenheimer coChelsea counsel coMirae asset global investments coMedicine incMedicine company profileGreen alpha advisorsPrime medicineGet free reportMedicine stock downDirector robert nelsenAsset global investmentsAlpha advisorsGet free

Prime Medicine, Inc (NYSE:PRME) Receives Average Recommendation of Moderate Buy from Analysts

Prime Medicine, Inc (NYSE:PRME) Receives Average Recommendation of Moderate Buy from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Robert nelsenStifel nicolausChelsea counsel coSg americas securitiesSecurities exchange commissionChina universal asset management coMedicine incPrime medicineGet free reportDirector robert nelsenExchange commissionUniversal asset managementGet freePrime editorsPrime editorPrime medicine daily

ASGT 2024: Gene Therapy Delivery and Development Dominates Opening Workshop

ASGT 2024: Gene Therapy Delivery and Development Dominates Opening Workshop
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

United statesBoston universityFeng zhangCameron glasscockSamagya banskotaMakoto saitoDavid bakerJulian grunewaldBrad loncarHolly reesKeith joungAmerican society of geneTechnical university of munichLiu labDevelopment of precision genome editing technologiesBroad institute

Levin Capital Strategies L P Makes New $177,000 Investment in Prime Medicine, Inc (NYSE:PRME)

Levin Capital Strategies L.P. purchased a new position in Prime Medicine, Inc. (NYSE:PRME – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 20,000 shares of the company’s stock, valued at approximately $177,000. Other hedge funds have also recently modified their holdings of […]

Stifel nicolausRobert nelsenMedicine company profileOppenheimer coChina universal asset management coSg americas securitiesProfund advisorsMedicine incPrime medicineFree reportUniversal asset managementGet free reportDirector robert nelsenPrime editorsPrime editorVisit holdingschannel

In Vivo Gene Editing Grants Access to Medical Treasures

In Vivo Gene Editing Grants Access to Medical Treasures
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

United statesMohammed asmalAmy simonDaniel dornbuschAmerican society of geneBeam therapeutics base editing applicationChief medical officerEngineered stem cell antibody pairedTherapeutics base editing applicationBeam therapeuticsPrime medicineCimeio therapeuticsMedicine prime editingChief executive officerExcision bioAmerican society